Science Explorer Back to mapMap
Discussion
Researcher · Kissei Pharmaceutical (Japan) · Japan

Masahiro Hiratochi

Masahiro Hiratochi publishes mostly in Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery, on topics such as Developmental Biology and Gene Regulation, Gout, Hyperuricemia, Uric Acid and Metabolism, Diabetes, and Cancer.

OpenAlex
World rank
#4,354,594
of 7,710,434 ranked researchers
Rank in Japan
#123,455
of 383,136
Works
17
Citations
741
Citations per work
43.6
h-index
11
i10-index 11Top 71% in Molecular Biology
Masahiro Hiratochi

What does Masahiro Hiratochi research?

Masahiro Hiratochi's work is mostly in Biochemistry, Genetics and Molecular Biology (36%), Medicine (24%), Neuroscience (4%).

Life Sciences: 7 works · 39.9% of their workBiochemistry, Genetics and Molecular Biology: 6 works · 35.5% of their workMolecular Biology: 5 works · 31.1% of their workPhysiology: 1 works · 4.4% of their workNeuroscience: 1 works · 4.4% of their workCellular and Molecular Neuroscience: 1 works · 4.4% of their workEverything else: 6 works · 35.6% of their workHealth Sciences: 4 works · 24.5% of their workMedicine: 4 works · 24.5% of their workEndocrinology, Diabetes and Metabolism: 2 works · 8.9% of their workSurgery: 2 works · 8.9% of their workNephrology: 1 works · 6.7% of their workTHEIR WORKMasahiroHiratochi17works
Life Sciences40%Health Sciences24%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology635.5%
    2. Neuroscience14.4%
  2. Everything else635.6%
    1. Medicine424.5%
  1. 1Molecular Biology31% of their works
  2. 2Endocrinology, Diabetes and Metabolism9% of their works
  3. 3Surgery9% of their works
  4. 4Nephrology7% of their works
  5. 5Physiology4% of their works
  6. 6Cellular and Molecular Neuroscience4% of their works

Research topics

Which keywords describe Masahiro Hiratochi's research?

The keywords of their largest research topics: Inflammation, Development, Hyperuricemia, Notch Signaling, Uric Acid, Adenosine Receptors, AMP-Activated Protein Kinase and Cardiovascular Outcomes.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 17 words, with their numbers
  1. Inflammation52 topics
  2. Development31 topic
  3. Hyperuricemia31 topic
  4. Notch Signaling31 topic
  5. Uric Acid31 topic
  6. AMP-Activated Protein Kinase21 topic
  7. Adenosine Receptors21 topic
  8. Cardiovascular Outcomes21 topic
  9. Dopamine21 topic
  10. Metformin21 topic
  11. Pancreatic Islets21 topic
  12. Pneumocystis21 topic
  13. Pneumonia21 topic
  14. Purinergic Signalling21 topic
  15. Serotonin21 topic
  16. Type 2 Diabetes21 topic
  17. ß-Cell Dysfunction21 topic

Where does Masahiro Hiratochi work?

Masahiro Hiratochi's main affiliation in the publication record is Kissei Pharmaceutical (Japan), Japan.

How many publications and citations does Masahiro Hiratochi have?

OpenAlex counts 17 works and 741 citations for Masahiro Hiratochi, an h-index of 11, ranking #4,354,594 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Masahiro Hiratochi. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.